German doctors plead for DRG (Diagnosis Related Groups) delay:
This article was originally published in Clinica
Germany's doctors last week demanded that the convergence phase of the diagnosis related groups (DRG) system for hospital reimbursement be delayed by five years. This would allow more time for doctors to adjust to the new system and establish a consensus for its final implementation. Following the introduction of the system on a voluntary basis at the start of 2003, certain DRGs were in need of improvement, delegates to the 106th German doctors' conference in Cologne heard. In addition, certain complex medical specialisms, such as dermatology and accident and emergency surgery were not properly reflected in DRGs, they were told. Furthermore, delegates agreed that DRGs should be structured so as to take into account costs incurred for the further education of doctors, to ensure quality care in the future.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.